Patients with type 2 diabetes that were treated with a weekly injection of the breakthrough drug Semaglutide were able to achieve an average weight loss of nearly 10kg, according to a new study published in The Lancet today.Read More
Obesity breakthrough supported by research from Leicester diabetes experts
Previous research in diabetes led by Leicester researchers has played a key role in laying foundations for new breakthrough in weight-loss treatment.Read More
Volunteers needed to help plan research
Volunteers are needed to help Leicester researchers design a programme for peripheral arterial disease screening, with the aim to improve heart and circulatory health. Read More
Project trials self-screening kiosks in Leicestershire workplaces to detect COVID-19
A project trialling the use of self-screening kiosks in Leicestershire workplaces to detect symptoms of COVID-19 has been launched by the University of Leicester through the Leicester Life Sciences Accelerator (LLSA) and the NIHR Leicester Biomedical Research Centre.Read More
Recruitment begins for ethnic minority healthcare staff COVID research study
A drive to encourage ethnic minority healthcare workers to participate in a Government-backed study investigating the risks of COVID-19 to their health has been launched today.Read More
Ethnicity and seniority among NHS staff impacts COVID-19 antibody prevalence
Ethnic minority healthcare workers are more likely to have built up antibodies to COVID-19, a team of researchers from Leicester has found.Read More